|
BR112012010705A2
(pt)
|
2009-11-05 |
2016-03-29 |
Glaxosmithkline Llc |
composto, composição farmacêutica, produto farmacêutico combinado, uso de um composto, e, métodos para tratar uma doença ou condição, e para inibir um bromodomínio
|
|
ME02360B
(me)
|
2009-11-05 |
2016-06-20 |
Glaxosmithkline Llc |
Inhibitor bromodomena benzodiazepina
|
|
EP2571875A4
(en)
|
2010-05-14 |
2013-10-30 |
Dana Farber Cancer Inst Inc |
CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
|
|
CA2799403C
(en)
|
2010-05-14 |
2020-01-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating leukemia
|
|
PL2571503T3
(pl)
|
2010-05-14 |
2015-06-30 |
Dana Farber Cancer Inst Inc |
Kompozycje i sposoby leczenia nowotworu, choroby zapalnej i innych zaburzeń
|
|
US9085582B2
(en)
|
2010-06-22 |
2015-07-21 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
GB201106743D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2705039B1
(en)
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2721031B1
(en)
|
2011-06-17 |
2016-01-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033269A1
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9271978B2
(en)
|
2012-12-21 |
2016-03-01 |
Zenith Epigenetics Corp. |
Heterocyclic compounds as bromodomain inhibitors
|
|
AU2014223990A1
(en)
*
|
2013-02-28 |
2015-09-10 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
PE20151596A1
(es)
|
2013-03-14 |
2015-11-24 |
Glaxosmithkline Intellectual Property N 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina 2,3-disustituidos y su uso como inhibidores del bromodominio
|
|
CA2903881C
(en)
|
2013-03-15 |
2021-05-18 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
EA027139B1
(ru)
|
2013-04-26 |
2017-06-30 |
Бейджин, Лтд. |
Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
|
|
SG11201510409QA
(en)
|
2013-06-21 |
2016-01-28 |
Zenith Epigenetics Corp |
Novel bicyclic bromodomain inhibitors
|
|
CA2915622C
(en)
|
2013-06-21 |
2020-08-18 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
US9290514B2
(en)
|
2013-07-08 |
2016-03-22 |
Incyte Holdings Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
US9855271B2
(en)
|
2013-07-31 |
2018-01-02 |
Zenith Epigenetics Ltd. |
Quinazolinones as bromodomain inhibitors
|
|
WO2015070020A2
(en)
|
2013-11-08 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
WO2015081203A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
CA2932040A1
(en)
*
|
2013-12-10 |
2015-06-18 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
WO2015095492A1
(en)
|
2013-12-19 |
2015-06-25 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
MX2016009976A
(es)
|
2014-01-31 |
2016-11-15 |
Dana Farber Cancer Inst Inc |
Derivados de diazepam y sus usos.
|
|
KR20160115953A
(ko)
|
2014-01-31 |
2016-10-06 |
다나-파버 캔서 인스티튜트 인크. |
디아미노피리미딘 벤젠술폰 유도체 및 그의 용도
|
|
CN106456653A
(zh)
|
2014-02-28 |
2017-02-22 |
腾沙治疗公司 |
高胰岛素血症相关病症的治疗
|
|
DK3674302T3
(da)
|
2014-04-23 |
2023-04-03 |
Incyte Holdings Corp |
1h-pyrrolo[2,3-c]pyridin-7(6h)-oner og pyrazolo[3,4-c]pyridin-7(6h)-oner som inhibitorer af bet-proteiner
|
|
ES2725928T3
(es)
|
2014-06-20 |
2019-09-30 |
Constellation Pharmaceuticals Inc |
Formas cristalinas de 2-((4S)-6-(4-clorofenil)-1-metil-4H-benzo[c]isoxazolo[4,5-e]azepin-4-il)acetamida
|
|
CA2955077A1
(en)
|
2014-08-08 |
2016-02-11 |
Dana-Farber Cancer Institute, Inc. |
Dihydropteridinone derivatives and uses thereof
|
|
WO2016022902A1
(en)
|
2014-08-08 |
2016-02-11 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
PT3191476T
(pt)
|
2014-09-12 |
2019-01-17 |
Glaxosmithkline Ip No 2 Ltd |
Derivados de tetra-hidroquinolina como inibidores de bromodomínio
|
|
EP3194406B8
(en)
|
2014-09-15 |
2021-03-31 |
Incyte Corporation |
Tricyclic heterocycles for use as bet protein inhibitors
|
|
US10179125B2
(en)
|
2014-12-01 |
2019-01-15 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
EP3227281A4
(en)
|
2014-12-01 |
2018-05-30 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
HK1245248B
(en)
|
2014-12-11 |
2020-05-15 |
恒翼生物医药(上海)股份有限公司 |
Substituted heterocycles as bromodomain inhibitors
|
|
HK1245247A1
(zh)
|
2014-12-17 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
WO2016198691A1
(en)
|
2015-06-11 |
2016-12-15 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
JP2018520124A
(ja)
|
2015-06-26 |
2018-07-26 |
テンシャ セラピューティクス，インコーポレイテッド |
Ｎｕｔ正中線癌の治療
|
|
KR20180049058A
(ko)
|
2015-09-11 |
2018-05-10 |
다나-파버 캔서 인스티튜트 인크. |
시아노 티에노트리아졸로디아제핀 및 그의 용도
|
|
JP2018526424A
(ja)
|
2015-09-11 |
2018-09-13 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
アセトアミドチエノトリアゾロジアゼピンおよびこれらの使用
|
|
AR106520A1
(es)
|
2015-10-29 |
2018-01-24 |
Incyte Corp |
Forma sólida amorfa de un inhibidor de proteína bet
|
|
CN114957291A
(zh)
|
2015-11-25 |
2022-08-30 |
达纳-法伯癌症研究所股份有限公司 |
二价溴结构域抑制剂及其用途
|
|
MA45122A
(fr)
|
2016-05-24 |
2019-04-10 |
Constellation Pharmaceuticals Inc |
Inhibiteurs hétérocycliques de cbp/ep300 et leur utilisation dans le traitement du cancer
|
|
CA3220957A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Crystalline solid forms of a bet inhibitor
|
|
US11028051B2
(en)
*
|
2016-12-13 |
2021-06-08 |
St. Jude Children's Research Hospital |
Tetrahydroquinoline-based bromodomain inhibitors
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
CN114751836B
(zh)
*
|
2021-02-23 |
2024-05-31 |
四川青木制药有限公司 |
3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
|
|
EP4511119A1
(en)
|
2022-04-19 |
2025-02-26 |
Nuevolution A/S |
Compounds active towards bromodomains
|